VELIN-PHARMA A/S: Financial statements 2020
CVR: 33026013
Source: annual report 2020, Danish Business Authority
01/06/2019 – 31/05/2020
VELIN-PHARMA A/S (CVR 33026013) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK 278,655 and a net result of DKK 3,483,807 compared with DKK -997,967 the year before. That is an increase of 100.4% compared with the year before. Equity in the 2020 report amounted to DKK 22,170,216. The solvency ratio was 97.6%.
- Gross Profit
- DKK 278,655
- Profit/Loss
- DKK 3,483,807
- Equity
- DKK 22,170,216
- Total Assets
- DKK 22,714,900
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2020 | - | 279 t. | 3.5 mio. | 22.2 mio. | - |
| 2019 | - | 139 t. | -998 t. | 18.7 mio. | - |
| 2018 | - | 86 t. | -807 t. | 19.7 mio. | - |
| 2017 | - | 164 t. | -147 t. | 20.5 mio. | - |
| 2016 | - | 439 t. | 1.1 mio. | 20.6 mio. | - |
Official annual report
How creditworthy is VELIN-PHARMA A/S?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreAbout VELIN-PHARMA A/S
VELIN-PHARMA A/S is a Danish company of the type Aktieselskab based in Fredensborg, founded in 1971. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named JOHANNES LARSENS EFTF.. V. OG F VELIN A/S and JOHANNES LARSENS EFTF., V. OG F. V ELIN A/S. The management consists of Flemming Velin. The board consists of Thomas Velin (chair), Flemming Velin and Majken Velin. The company's owners include Flemming Velin, Majken Velin and Thomas Velin. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK 94,968 and a net result of DKK -16,021,366 compared with DKK 12,695,295 the year before. Equity in the 2025 report amounted to DKK 33,462,658.